Clinical trial
A Study to Evaluate the Efficacy and Safety of CCX282-B in Subjects With…
NCT00306215 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00306215 |
|---|---|
| Title | A Study to Evaluate the Efficacy and Safety of CCX282-B in Subjects With Moderate to Severe Crohn's Disease |
| Official title | A Multinational, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of CCX282-B in Subjects With Moderate to Severe Crohn's Disease |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Crohn's Disease |
| Intervention type | Drug |
| Interventions | CCX282-B |
| Enrollment | 436 |
| Start date | Mar 1, 2006 |
| Primary completion | Aug 1, 2008 |
| Completion | Jun 1, 2009 |
| First posted | Mar 23, 2006 |
| Last update posted | Mar 6, 2025 |
| Countries | Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Czechia, Denmark, France, Germany, Hungary, Israel and 5 more |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: